About Fertin Pharma Research and Development India Private Limited
Data last updated:
Fertin Pharma Research and Development India Private Limited was a foreign private limited company based in Salcete, Goa, India, operated as a subsidiary of Fertin Pharma As. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 28 March 2011.
The company was registered with the Registrar of Companies (ROC), Goa, under CIN U73100GA2011FTC013586. Its GSTIN is 27AABCF7053Q1Z4 (Maharashtra). The company held 2 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹1.84 Cr. It was led by directors including Ravi Kumar Seshadri (Managing Director) and Peter Halling.
Its last annual general meeting (AGM) was held on 30 December 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at L – 10 & L – 11 Cuncolim Industrial Estate Cuncolim, Salcete, Goa, India – 403703.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.72 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.22 Cr (net margin 12.6%) and EBITDA of ₹2.58 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The company had about 26 employees on its provident fund (EPFO) records before it was dissolved.
Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.
The last known website on record is fertin.com.
Company details
CIN history
Fertin Pharma Research and Development India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100GA2011FTC013586, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100GA2011FTC013586 | Current |
| U73100TG2011FTC081627 | Previous |
| U73100AP2011FTC081627 | Previous |
Contact details
Fertin Pharma Research and Development India Private Limited's registered office is in Salcete, Goa. Its website is fertin.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressL – 10 & L – 11 Cuncolim Industrial Estate Cuncolim, Salcete, Goa, India – 403703
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Fertin Pharma Research and Development India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fertin Pharma Research and Development India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Fertin Pharma Research and Development India Private Limited, buy the company report.
Financials of Fertin Pharma Research and Development India Private Limited
FY 2022 filings availableFertin Pharma Research and Development India Private Limited reported revenue of ₹9.72 Cr (up 8% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 8% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.5% | ||||
| Net Profit Margin | 12.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fertin Pharma Research and Development India Private Limited, buy the company report.
Board of directors of Fertin Pharma Research and Development India Private Limited
Fertin Pharma Research and Development India has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Peter Halling | Director | 30 Sep 2020 | 6 Years 1 Months | As last reported |
| Ravi Kumar Seshadri Also directs: Fertin India Private Limited, Aspeya India Private Limited | Managing Director | 05 Sep 2011 | 15 Years 1 Months | As last reported |
| Michael Henrik Thomsen Also directs: Fertin India Private Limited, Aspeya India Private Limited | Director | 14 Dec 2017 | 8 Years 10 Months | As last reported |
| Lene Frederiksen Lind Also directs: Fertin India Private Limited | Director | 20 Dec 2021 | 4 Years 10 Months | As last reported |
Peer comparison
Fertin Pharma Research and Development India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catawba Research (India) Private Limited | ₹9.86 Cr (FY 2025) | -2.0% | Mumbai, Maharashtra, India | |||
| Fertin Pharma Research and Development India Private Limitedthis company | ₹9.72 Cr (FY 2022) | ₹1.22 Cr | 12.6% | 8.0% | 26 | Salcete, Goa, India |
| Novumgen Private Limited | ₹9.49 Cr (FY 2024) | 77.0% | Vadodara, Gujarat, India | |||
| Zasya Life Sciences Private Limited | ₹9.37 Cr (FY 2025) | 3.0% | Amipura, Gujarat, India |
To see the full peer comparison of Fertin Pharma Research and Development India Private Limited, buy the company report.
Auditor
Fertin Pharma Research and Development India Private Limited is audited by C B G & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C B G & ASSOCIATES | FY 2020 | 116664W |
Shareholding
The shareholding of Fertin Pharma Research and Development India Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Fertin Pharma Research and Development India Private Limited, buy the company report.
Legal cases
Fertin Pharma Research and Development India Private Limited has 3 court cases on record: 1 filed by Fertin Pharma Research and Development India, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of CGST and Central Excise,Navi Mumbai | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by The Commissioner of CGST and Central Excise,Navi Mumbai | Disposed |
To see the full case history of Fertin Pharma Research and Development India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fertin Pharma Research and Development India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fertin Pharma Research and Development India Private Limited has a workforce of 26 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Fertin Pharma Research and Development India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCF7053Q1Z4 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fertin Pharma Research and Development India Private Limited, buy the company report.
Recent activity
Fertin Pharma Research and Development India Private Limited has 13 board changes on record since 2011: 4 appointments and 9 cessations. The latest: Lene Frederiksen Lind ceased to be Additional Director on 30 Mar 2023.
4 earlier events are in the company report.
News
Frequently asked questions
Fertin Pharma Research and Development India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Fertin Pharma Research and Development India was a foreign private limited company based in Salcete, Goa, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 28 March 2011 and is registered under CIN U73100GA2011FTC013586. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Fertin Pharma Research and Development India was incorporated on 28 March 2011. It is registered with the Registrar of Companies, Goa.
Fertin Pharma Research and Development India had 4 directors:
- Ravi Kumar Seshadri - Managing Director
- Peter Halling - Director
- Michael Henrik Thomsen - Director
- Lene Frederiksen Lind - Director
The CIN (Corporate Identification Number) of Fertin Pharma Research and Development India is U73100GA2011FTC013586. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Fertin Pharma Research and Development India is at L – 10 & L – 11 Cuncolim Industrial Estate Cuncolim, Salcete, Goa, India – 403703.
Fertin Pharma Research and Development India can be reached through the website fertin.com. Its registered office is in Salcete, Goa, India.
The latest financial statements of Fertin Pharma Research and Development India on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 December 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Fertin Pharma Research and Development India is 27AABCF7053Q1Z4, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
Fertin Pharma Research and Development India operated in the pharma industry, in the pharma contract r and d segment.
The peers of Fertin Pharma Research and Development India by revenue are Catawba Research (India) Private Limited, Novumgen Private Limited, Zasya Life Sciences Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
